Renee Gaeta

CIK: 0001742428

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Outset Medical, Inc.

Officer

CADL

Candel Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

OM
Outset Medical, Inc.
Aug 17, 2026
Sale(S)
Direct
4.5K shares at avg. $4.39$20K
OM
Outset Medical, Inc.
Jun 26, 2026
Award(A)
Direct
71.6K shares-
CADL
Candel Therapeutics, Inc.
Jun 23, 2026
Award(A)
Stock Option (Right to Buy)
Direct
32K shares-
OM
Outset Medical, Inc.
Jun 3, 2026
Sale(S)
Direct
17.7K shares at avg. $4.94$87K
CADL
Candel Therapeutics, Inc.
Jun 17, 2025
Award(A)
Stock Option (Right to Buy)
Direct
14.2K shares-
OM
Outset Medical, Inc.
Jun 10, 2025
Award(A)
Direct
131.4K shares-

		Type	Shares	Price		Ownership
Aug 17, 2026	OM Outset Medical, Inc.	Sale(S)	4,543	$4.39	$19,944	Direct
Jun 26, 2026	OM Outset Medical, Inc.	Award(A)	71,630	-	$0	Direct
Jun 23, 2026	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	32,000	-	-	Direct
Jun 3, 2026	OM Outset Medical, Inc.	Sale(S)	17,672	$4.94	$87,300	Direct
Jun 17, 2025	CADL Candel Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	14,240	-	-	Direct
Jun 10, 2025	OM Outset Medical, Inc.	Award(A)	131,425	-	-	Direct

1-6 of 6 transactions

About Gaeta Renee

Gaeta Renee (SEC CIK 0001742428) files insider reports with the SEC as Chief Financial Officer of Outset Medical, Inc. (OM) and Director of Candel Therapeutics, Inc. (CADL).

Signal8 holds 7 ownership filings by Gaeta Renee (1 Form 3, 6 Form 4), filed between Jun 3, 2025 and Aug 18, 2026. Those filings report 6 transactions, from Jun 10, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Gaeta Renee's filings is in SAN JOSE, CA.

Recent filings by Gaeta Renee

Aug 17, 2026: Open-market sale of OM shares (Form 4, code S).
Jun 26, 2026: Grant or award of OM shares (Form 4, code A).
Jun 23, 2026: Grant or award of CADL derivative securities (Form 4, code A).
Jun 3, 2026: Open-market sale of OM shares (Form 4, code S).
Jun 17, 2025: Grant or award of CADL derivative securities (Form 4, code A).

Other insiders filing for Outset Medical, Inc. (OM)

Leonard Braden Michael, 10% Owner
Trigg Leslie, Chair and CEO
Brottem John L., General Counsel
HACKETT PATRICK T, Director
OBOYLE KEVIN C, Director
Prange Karen, Director

How to read Form 4 transaction codes